locus mbio paper

Kurt Selle (Locus Biosciences) and colleagues, in collaboration with NC State University, have published a new paper in mBio showing that phage-delivered programmable CRISPR therapeutics (recombinant phage expressing host genome-targeting CRISPR RNAs) can effectively target C. difficile in vivo. mBio paper | NC State News article